Hims (Hims & Hers Health, Inc.) is one of the largest direct-to-consumer telehealth platforms in the US, serving over 2.5 million subscribers. As a publicly traded company (NYSE: HIMS), they've built massive scale and trust in the men's health space. Their ED treatments start as low as $4 per dose for generic Sildenafil, making them one of the most affordable options. They also offer Hard Mints (chewable ED meds) starting at just $1.63 per use. For hair loss, their oral Finasteride starts at $22/month, with combination topical treatments available at $35/month. Hims' weight loss program features compounded Semaglutide (GLP-1) at $199/month - significantly cheaper than brand-name alternatives. For testosterone support, they currently offer Enclomiphene-based treatment at $99/month, with injectable TRT launching in 2026. While some customers report subscription management challenges, the platform excels at convenience, pricing, and accessibility. All consultations are free, prescriptions are handled online, and everything ships discreetly to your door.